MedTrace Logo

A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache

NCT00287781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2008-01-25

No results posted yet for this study

Summary

Migraine headaches have previously been shown to be responsive to intranasal lidocaine in a small study. Using a nebulizer to administer the drug would improve the feasibility of using the treatment. It would also spare the patient narcotics with their attendant side effects. Because of the potential for placebo effect a placebo control is necessary in this study.

Conditions

  • Migraine Headache

Interventions

DRUG

Lidocaine

Sponsors & Collaborators

  • Kern Medical Center

    lead OTHER

Principal Investigators

  • Rick McPheeters, DO FAAEM · Kern Medical Center UCLA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Completion
2006-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00287781 on ClinicalTrials.gov